Literature DB >> 22419572

Variations in non-pharmacological anti-infective measures in childhood leukemia--results of an international survey.

Thomas Lehrnbecher1, Richard Aplenc, Fernanda Rivas Pereira, Alvaro Lassaletta, Désirée Caselli, Jerzy Kowalczyk, Julia Chisholm, Lillian Sung.   

Abstract

BACKGROUND: Standardization in clinical practice may lead to improved outcomes. Unfortunately, little is known about the variability of non-pharmacological anti-infective measures in children with cancer. DESIGN AND METHODS: A web-based survey assessed institutional recommendations regarding restrictions of social contacts, pets and food and instructions on wearing face masks in public for children with standard- risk acute lymphoblastic leukemia and acute myeloid leukemia during intensive chemotherapy.
RESULTS: A total of 336 institutions in 27 countries responded to the survey (range, 1-76 institutions per country; overall response rate 61%). Most institutions recommend that patients with acute myeloid leukemia avoid indoor public places and daycare, kindergarten and school, whereas recommendations for patients with acute lymphoblastic leukemia differ considerably by institution. In terms of restrictions related to pets, there was a wide variability between institutions for both acute lymphoblastic and acute myeloid leukemia patients. Most, but not all institutions do not allow children with either acute lymphoblastic or acute myeloid leukemia to eat raw meat, raw seafood or unpasteurized milk. Whereas most institutions do not routinely recommend that patients with acute lymphoblastic leukemia wear face masks in public, advice on this matter varies for patients with acute myeloid leukemia.
CONCLUSIONS: The survey demonstrates that there is a wide variation in recommendations on non-pharmacological anti-infective measures between different institutions, countries and continents. This information may be used to encourage harmonization of supportive care practices and future clinical trials.

Entities:  

Mesh:

Year:  2012        PMID: 22419572      PMCID: PMC3487555          DOI: 10.3324/haematol.2012.062885

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  17 in total

Review 1.  The neutropenic diet: what's the evidence?

Authors:  Karen Moody; Mary E Charlson; Jonathan Finlay
Journal:  J Pediatr Hematol Oncol       Date:  2002-12       Impact factor: 1.289

2.  Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia.

Authors:  Lillian Sung; Beverly J Lange; Robert B Gerbing; Todd A Alonzo; James Feusner
Journal:  Blood       Date:  2007-07-27       Impact factor: 22.113

3.  Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI).

Authors:  D R Hargrave; I I Hann; S M Richards; F G Hill; J S Lilleyman; S Kinsey; C C Bailey; J M Chessells; C Mitchell; O B Eden
Journal:  Br J Haematol       Date:  2001-02       Impact factor: 6.998

Review 4.  Putting evidence into practice: prevention of infection.

Authors:  Laura J Zitella; Christopher R Friese; Joanna Hauser; Barbara Holmes Gobel; Myra Woolery; Colleen O'Leary; Felicia A Andrews
Journal:  Clin J Oncol Nurs       Date:  2006-12       Impact factor: 1.027

5.  Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

Authors:  M Schrappe; A Reiter; M Zimmermann; J Harbott; W D Ludwig; G Henze; H Gadner; E Odenwald; H Riehm
Journal:  Leukemia       Date:  2000-12       Impact factor: 11.528

6.  Feasibility and safety of a pilot randomized trial of infection rate: neutropenic diet versus standard food safety guidelines.

Authors:  Karen Moody; Jonathan Finlay; Carol Mancuso; Mary Charlson
Journal:  J Pediatr Hematol Oncol       Date:  2006-03       Impact factor: 1.289

7.  Liposomal amphotericin B twice weekly as antifungal prophylaxis in paediatric haematological malignancy patients.

Authors:  K Bochennek; L Tramsen; N Schedler; M Becker; T Klingebiel; A H Groll; T Lehrnbecher
Journal:  Clin Microbiol Infect       Date:  2011-09-06       Impact factor: 8.067

8.  Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.

Authors:  Lillian Sung; Paul C Nathan; Beverly Lange; Joseph Beyene; George R Buchanan
Journal:  J Clin Oncol       Date:  2004-08-15       Impact factor: 44.544

9.  Incidence of bacteremias and invasive mycoses in children undergoing allogeneic hematopoietic stem cell transplantation: a single center experience.

Authors:  E Castagnola; F Bagnasco; M Faraci; I Caviglia; S Caruso; B Cappelli; C Moroni; G Morreale; A Timitilli; G Tripodi; E Lanino; R Haupt
Journal:  Bone Marrow Transplant       Date:  2007-11-19       Impact factor: 5.483

10.  The effect of the neutropenic diet in the outpatient setting: a pilot study.

Authors:  Debra DeMille; Priscilla Deming; Paul Lupinacci; Linda A Jacobs
Journal:  Oncol Nurs Forum       Date:  2006-11-03       Impact factor: 2.172

View more
  5 in total

1.  Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.

Authors:  Hiroto Inaba; Aditya H Gaur; Xueyuan Cao; Patricia M Flynn; Stanley B Pounds; Viswatej Avutu; Lindsay N Marszal; Scott C Howard; Ching-Hon Pui; Raul C Ribeiro; Randall T Hayden; Jeffrey E Rubnitz
Journal:  Cancer       Date:  2014-03-26       Impact factor: 6.860

2.  Zoonotic infections in pediatric patients with acute leukemia.

Authors:  Katherine Lothstein; Brian Fisher; Yimei Li; Alix Seif; Tracey Harris; Kari Torp; Marko Kavcic; Yuan-Shung V Huang; Susan R Rheingold; Richard Aplenc
Journal:  Pediatr Blood Cancer       Date:  2013-08-19       Impact factor: 3.167

Review 3.  Prophylactic Measures During Induction for Acute Myeloid Leukemia.

Authors:  Matthew W McCarthy; Thomas J Walsh
Journal:  Curr Oncol Rep       Date:  2017-03       Impact factor: 5.075

4.  Lack of Effectiveness of Neutropenic Diet and Social Restrictions as Anti-Infective Measures in Children With Acute Myeloid Leukemia: An Analysis of the AML-BFM 2004 Trial.

Authors:  Lars Tramsen; Emilia Salzmann-Manrique; Konrad Bochennek; Thomas Klingebiel; Dirk Reinhardt; Ursula Creutzig; Lillian Sung; Thomas Lehrnbecher
Journal:  J Clin Oncol       Date:  2016-06-06       Impact factor: 44.544

Review 5.  Academic Continuity and School Reentry Support as a Standard of Care in Pediatric Oncology.

Authors:  Amanda L Thompson; Heather L Christiansen; Megan Elam; Jennifer Hoag; Mary Kay Irwin; Maryland Pao; Megan Voll; Robert B Noll; Katherine Patterson Kelly
Journal:  Pediatr Blood Cancer       Date:  2015-12       Impact factor: 3.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.